SEC Form D · Amendment · filed October 31, 2019
MIRAGEN THERAPEUTICS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Kevin E. Koch · Boulder, CODirectorThomas E. Hughes · Boulder, CODirectorArlene M. Morris · Boulder, CODirectorJason A. Leverone · Boulder, COExecWilliam S. Marshall · Boulder, COExec · DirectorPaul D. Rubin · Boulder, COExecJeffrey S. Hatfield · Boulder, CODirectorChristopher D. Bowden · Boulder, CODirectorJoseph L. Turner · San Ramon, CADirectorQuentin W. Kahrau · Seattle, WADirectorWalter Cook · New York, NYExecRoss A. Buhrdorf · Terrell, TXDirectorAnthony B. Lennen · Indianapolis, INExecMark Carhart · New York, NYDirectorPaul Lidsky · New York, NYDirectorAnish J. Parvatanini · CHICAGO, ILDirectorJames, Iii B. Mcginty · Terrell, TXDirectorArjuna J. Ariathurai · CHICAGO, ILDirectorAmy D. Glover · Indianapolis, INExec · DirectorPhilip B. Palmer · SAVANNAH, GAExec · DirectorPaul G. Smith · Omaha, NEDirectorHoward D. Ellis · Overland Park, KSExecNull Assure Fund Management Ii · Salt Lake City, UTDirectorAaron Greenwald · New York, NYDirectorDavid Ertel · Coral Gables, FLDirectorTomas N. Diaz Mathe · Irving, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗